GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » Total Assets

Aker BioMarine ASA (OSL:AKBM) Total Assets : kr8,633 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA Total Assets?

Aker BioMarine ASA's Total Assets for the quarter that ended in Mar. 2024 was kr8,633 Mil.

Warning Sign:

If a company builds assets at 15.4% a year, faster than its revenue growth rate of 10.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Aker BioMarine ASA's average Total Assets Growth Rate was -0.10% per year. During the past 3 years, the average Total Assets Growth Rate was 12.00% per year. During the past 5 years, the average Total Assets Growth Rate was 15.40% per year. During the past 10 years, the average Total Assets Growth Rate was 22.20% per year.

During the past 12 years, Aker BioMarine ASA's highest 3-Year average Total Assets Growth Rate was 49.60%. The lowest was -0.90%. And the median was 12.00%.

Total Assets is connected with ROA %. Aker BioMarine ASA's annualized ROA % for the quarter that ended in Mar. 2024 was -5.82%. Total Assets is also linked to Revenue through Asset Turnover. Aker BioMarine ASA's Asset Turnover for the quarter that ended in Mar. 2024 was 0.10.


Aker BioMarine ASA Total Assets Historical Data

The historical data trend for Aker BioMarine ASA's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA Total Assets Chart

Aker BioMarine ASA Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,246.62 6,098.73 6,803.18 8,125.39 8,725.41

Aker BioMarine ASA Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,611.21 8,849.81 8,743.85 8,725.41 8,632.94

Aker BioMarine ASA Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Aker BioMarine ASA's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=3866.355+4859.054
=8,725

Aker BioMarine ASA's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=3764.112+4868.831
=8,633

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aker BioMarine ASA  (OSL:AKBM) Total Assets Explanation

Total Assets is connected with ROA %.

Aker BioMarine ASA's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-505.136/( (8725.409+8632.943)/ 2 )
=-505.136/8679.176
=-5.82 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Aker BioMarine ASA's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=830.927/( (8725.409+8632.943)/ 2 )
=830.927/8679.176
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Aker BioMarine ASA Total Assets Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Aker BioMarine ASA (OSL:AKBM) Business Description

Traded in Other Exchanges
Address
Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines